Kiora Pharmaceuticals (KPRX) Shares Issued (2017 - 2022)
Kiora Pharmaceuticals' (KPRX) quarterly Shares Issued came in at $12650.0 in Q3 2022, up 149.41% YoY from $5072.0 in Q3 2021, and down 97.58% on a QoQ basis from $522066.0 in Q2 2022.
Kiora Pharmaceuticals (KPRX) Shares Issued (2017 - 2022) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 6 years of Shares Issued data on file, last reported at $12650.0 in Q3 2022.
- Quarterly Shares Issued rose 149.41% year-over-year to $12650.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $12650.0 (up 149.41% YoY) and the FY2021 annual result came in at $12952.0, up 107.27% from the prior year.
- Shares Issued declined to $12650.0 in Q3 2022, from $522066.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $522066.0 in Q2 2022 to a low of $5072.0 in Q3 2021.
- A 5-year average of $150993.4 and a median of $142035.0 in 2018 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2020 — Shares Issued sank 96.41% — and 2022, when it jumped 162.58%.
- Tracing KPRX's Shares Issued over 5 years: stood at $138324.0 in 2018, then rose by 25.92% to $174175.0 in 2019, then slumped by 96.41% to $6249.0 in 2020, then jumped by 107.27% to $12952.0 in 2021, then retreated by 2.33% to $12650.0 in 2022.
- The last three Shares Issued figures came in at $12650.0 (Q3 2022), $522066.0 (Q2 2022), and $241683.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Kiora Pharmaceuticals | 15.64 Mn | 15.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 12,650.00 |
| Sep 30, 2022 | 12,650.00 |
| Jun 30, 2022 | 522,066.00 |
| Jun 30, 2022 | 522,066.00 |
| Mar 31, 2022 | 241,683.00 |
| Mar 31, 2022 | 241,683.00 |
| Dec 31, 2021 | 12,952.00 |
| Dec 31, 2021 | 12,952.00 |
| Sep 30, 2021 | 5,072.00 |
| Sep 30, 2021 | 5,072.00 |
| Jun 30, 2021 | 198,822.00 |
| Jun 30, 2021 | 198,822.00 |
| Mar 31, 2021 | 130,865.00 |
| Mar 31, 2021 | 130,865.00 |
| Dec 31, 2020 | 6,249.00 |
| Dec 31, 2020 | 6,249.00 |
| Sep 30, 2020 | 93,165.00 |
| Sep 30, 2020 | 93,165.00 |
| Jun 30, 2020 | 134,574.00 |
| Jun 30, 2020 | 134,574.00 |